BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22414547)

  • 1. Decreased expression of T-cadherin is associated with gastric cancer prognosis.
    Tang Y; Dai Y; Huo J
    Hepatogastroenterology; 2012 Jun; 59(116):1294-8. PubMed ID: 22414547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
    Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
    Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer.
    Chen Y; Pan K; Li S; Xia J; Wang W; Chen J; Zhao J; Lü L; Wang D; Pan Q; Wang Q; Li Y; He J; Li Q
    J Surg Oncol; 2012 Sep; 106(3):286-93. PubMed ID: 22095633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively?
    Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
    Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
    Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis.
    Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
    Biochem Biophys Res Commun; 2004 Jun; 319(2):562-8. PubMed ID: 15178443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
    Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
    J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
    Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
    Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
    Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
    Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
    Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
    Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
    J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
    Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
    Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
    Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
    Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
    Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.